CN115068533A - 一种防治口腔疾病的中药组合物及护理产品 - Google Patents
一种防治口腔疾病的中药组合物及护理产品 Download PDFInfo
- Publication number
- CN115068533A CN115068533A CN202210801006.3A CN202210801006A CN115068533A CN 115068533 A CN115068533 A CN 115068533A CN 202210801006 A CN202210801006 A CN 202210801006A CN 115068533 A CN115068533 A CN 115068533A
- Authority
- CN
- China
- Prior art keywords
- parts
- traditional chinese
- chinese medicine
- pain
- medicine composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 29
- 239000000203 mixture Substances 0.000 title claims abstract description 27
- 230000000474 nursing effect Effects 0.000 title abstract description 8
- 208000025157 Oral disease Diseases 0.000 title abstract description 6
- 208000030194 mouth disease Diseases 0.000 title abstract description 6
- 208000032843 Hemorrhage Diseases 0.000 claims abstract description 34
- 208000002193 Pain Diseases 0.000 claims abstract description 32
- 230000036407 pain Effects 0.000 claims abstract description 32
- 230000000740 bleeding effect Effects 0.000 claims abstract description 27
- 244000131316 Panax pseudoginseng Species 0.000 claims abstract description 19
- 235000003181 Panax pseudoginseng Nutrition 0.000 claims abstract description 19
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 claims abstract description 19
- 244000236658 Paeonia lactiflora Species 0.000 claims abstract description 14
- 235000008598 Paeonia lactiflora Nutrition 0.000 claims abstract description 14
- 235000002566 Capsicum Nutrition 0.000 claims abstract description 12
- 235000006679 Mentha X verticillata Nutrition 0.000 claims abstract description 12
- 235000002899 Mentha suaveolens Nutrition 0.000 claims abstract description 12
- 235000001636 Mentha x rotundifolia Nutrition 0.000 claims abstract description 12
- 239000006002 Pepper Substances 0.000 claims abstract description 12
- 235000016761 Piper aduncum Nutrition 0.000 claims abstract description 12
- 235000017804 Piper guineense Nutrition 0.000 claims abstract description 12
- 235000008184 Piper nigrum Nutrition 0.000 claims abstract description 12
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims abstract description 12
- 229910052602 gypsum Inorganic materials 0.000 claims abstract description 12
- 239000010440 gypsum Substances 0.000 claims abstract description 12
- 235000002639 sodium chloride Nutrition 0.000 claims abstract description 12
- 239000011780 sodium chloride Substances 0.000 claims abstract description 12
- 240000004534 Scutellaria baicalensis Species 0.000 claims abstract description 11
- 235000017089 Scutellaria baicalensis Nutrition 0.000 claims abstract description 11
- 240000004510 Agastache rugosa Species 0.000 claims abstract description 9
- 206010061218 Inflammation Diseases 0.000 claims abstract description 9
- 230000004054 inflammatory process Effects 0.000 claims abstract description 9
- 208000004371 toothache Diseases 0.000 claims abstract description 9
- 230000003467 diminishing effect Effects 0.000 claims abstract description 8
- 241001116742 Drynaria Species 0.000 claims abstract description 4
- 208000020670 canker sore Diseases 0.000 claims abstract description 4
- 241000245665 Taraxacum Species 0.000 claims description 15
- 208000007117 Oral Ulcer Diseases 0.000 claims description 14
- 208000002399 aphthous stomatitis Diseases 0.000 claims description 14
- 241000722363 Piper Species 0.000 claims description 11
- 208000002925 dental caries Diseases 0.000 claims description 11
- 239000000606 toothpaste Substances 0.000 claims description 10
- 229940034610 toothpaste Drugs 0.000 claims description 10
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 6
- 238000002360 preparation method Methods 0.000 claims description 4
- 241001529821 Agastache Species 0.000 claims description 3
- 241001162994 Rugosus Species 0.000 claims description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 3
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 claims description 2
- 230000036592 analgesia Effects 0.000 claims description 2
- 230000003110 anti-inflammatory effect Effects 0.000 claims description 2
- 239000000679 carrageenan Substances 0.000 claims description 2
- 235000010418 carrageenan Nutrition 0.000 claims description 2
- 229920001525 carrageenan Polymers 0.000 claims description 2
- 229940113118 carrageenan Drugs 0.000 claims description 2
- 230000023597 hemostasis Effects 0.000 claims description 2
- 235000019333 sodium laurylsulphate Nutrition 0.000 claims description 2
- 239000000230 xanthan gum Substances 0.000 claims description 2
- 235000010493 xanthan gum Nutrition 0.000 claims description 2
- 229920001285 xanthan gum Polymers 0.000 claims description 2
- 229940082509 xanthan gum Drugs 0.000 claims description 2
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 claims description 2
- 241001474977 Palla Species 0.000 claims 1
- 229960005150 glycerol Drugs 0.000 claims 1
- 235000011187 glycerol Nutrition 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 19
- 240000001949 Taraxacum officinale Species 0.000 abstract description 4
- 230000035876 healing Effects 0.000 abstract description 2
- 244000203593 Piper nigrum Species 0.000 abstract 1
- 208000034158 bleeding Diseases 0.000 description 25
- 210000000214 mouth Anatomy 0.000 description 8
- 230000000052 comparative effect Effects 0.000 description 7
- 238000004140 cleaning Methods 0.000 description 6
- 210000004185 liver Anatomy 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 241000196324 Embryophyta Species 0.000 description 5
- 206010042674 Swelling Diseases 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- 230000008961 swelling Effects 0.000 description 5
- 231100000331 toxic Toxicity 0.000 description 5
- 230000002588 toxic effect Effects 0.000 description 5
- 230000000844 anti-bacterial effect Effects 0.000 description 4
- 210000003734 kidney Anatomy 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- 240000003870 Ageratum houstonianum Species 0.000 description 3
- 239000012459 cleaning agent Substances 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 241000411851 herbal medicine Species 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 239000003206 sterilizing agent Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 206010006326 Breath odour Diseases 0.000 description 2
- 206010007247 Carbuncle Diseases 0.000 description 2
- 241000721047 Danaus plexippus Species 0.000 description 2
- 208000019505 Deglutition disease Diseases 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 206010059866 Drug resistance Diseases 0.000 description 2
- 206010018276 Gingival bleeding Diseases 0.000 description 2
- 206010018291 Gingival swelling Diseases 0.000 description 2
- 208000032139 Halitosis Diseases 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- HUMNYLRZRPPJDN-UHFFFAOYSA-N benzaldehyde Chemical compound O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000005906 menstruation Effects 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 239000013588 oral product Substances 0.000 description 2
- GGHMUJBZYLPWFD-UHFFFAOYSA-N patchoulialcohol Chemical compound C1CC2(C)C3(O)CCC(C)C2CC1C3(C)C GGHMUJBZYLPWFD-UHFFFAOYSA-N 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 description 1
- 239000005770 Eugenol Substances 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 208000024283 Gingival haemorrhages Diseases 0.000 description 1
- 206010018286 Gingival pain Diseases 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 206010028034 Mouth ulceration Diseases 0.000 description 1
- 235000006484 Paeonia officinalis Nutrition 0.000 description 1
- 241001106477 Paeoniaceae Species 0.000 description 1
- 235000003143 Panax notoginseng Nutrition 0.000 description 1
- 241000180649 Panax notoginseng Species 0.000 description 1
- GGHMUJBZYLPWFD-MYYUVRNCSA-N Patchouli alcohol Natural products O[C@@]12C(C)(C)[C@H]3C[C@H]([C@H](C)CC1)[C@]2(C)CC3 GGHMUJBZYLPWFD-MYYUVRNCSA-N 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 240000002505 Pogostemon cablin Species 0.000 description 1
- 235000011751 Pogostemon cablin Nutrition 0.000 description 1
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 description 1
- 201000004328 Pulpitis Diseases 0.000 description 1
- 206010037464 Pulpitis dental Diseases 0.000 description 1
- 241000593989 Scardinius erythrophthalmus Species 0.000 description 1
- 241000207929 Scutellaria Species 0.000 description 1
- 208000004078 Snake Bites Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940124599 anti-inflammatory drug Drugs 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 239000012752 auxiliary agent Substances 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 230000001680 brushing effect Effects 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 230000007012 clinical effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 239000000551 dentifrice Substances 0.000 description 1
- 230000000249 desinfective effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 230000006806 disease prevention Effects 0.000 description 1
- 206010013663 drug dependence Diseases 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 235000006694 eating habits Nutrition 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- 229960002217 eugenol Drugs 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 210000001097 facial muscle Anatomy 0.000 description 1
- 210000000256 facial nerve Anatomy 0.000 description 1
- 239000010794 food waste Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000002008 hemorrhagic effect Effects 0.000 description 1
- 230000002439 hemostatic effect Effects 0.000 description 1
- 239000006049 herbal material Substances 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000002735 inhibitory effect on pain Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 239000008274 jelly Substances 0.000 description 1
- 230000006651 lactation Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 description 1
- 210000002200 mouth mucosa Anatomy 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 201000009240 nasopharyngitis Diseases 0.000 description 1
- 201000005111 ocular hyperemia Diseases 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- QNGNSVIICDLXHT-UHFFFAOYSA-N para-ethylbenzaldehyde Natural products CCC1=CC=C(C=O)C=C1 QNGNSVIICDLXHT-UHFFFAOYSA-N 0.000 description 1
- 208000004480 periapical periodontitis Diseases 0.000 description 1
- 208000028169 periodontal disease Diseases 0.000 description 1
- 201000001245 periodontitis Diseases 0.000 description 1
- 238000000554 physical therapy Methods 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 208000003265 stomatitis Diseases 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 208000011117 substance-related disease Diseases 0.000 description 1
- 230000009747 swallowing Effects 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 229940126673 western medicines Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
- A61K36/12—Filicopsida or Pteridopsida
- A61K36/126—Drynaria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/288—Taraxacum (dandelion)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/532—Agastache, e.g. giant hyssop
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/534—Mentha (mint)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/539—Scutellaria (skullcap)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/758—Zanthoxylum, e.g. pricklyash
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Marine Sciences & Fisheries (AREA)
- Zoology (AREA)
- Neurosurgery (AREA)
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种防治口腔疾病的中药组合物及护理产品,以质量份数计,包括100‑150份白芍药、70‑120份蒲公英、50‑120份海螵蛸、50‑200份海盐、70‑150份三七、40‑90份生石膏、50‑100份藿香、80‑140份骨碎补、30‑80份薄荷、50‑100份黄芩、50‑100份花椒。其具有能够高效消炎镇痛止血,防治蛀牙疼痛、出血,加速口腔溃疡痊愈之功效。
Description
技术领域
本发明属于口腔防治护理领域,具体来说是一种口腔疾病防治和护理中药组合物产品。
背景技术
由于当代食物的多样性,饮食结构复杂性等因素,龋齿现象依然非常普遍。龋齿俗称虫牙、蛀牙,是细菌性疾病,它可以引发继发牙髓炎和根尖周炎,导致疼痛、出血。
虽然当代人对口腔卫生也比较注重,市面上用于口腔清洁、护理产品众多,但生活规律改变,饮食习惯及生活压力等因素影响,蛀牙疼痛、出血在日常生活中经常出现,这是因为缺乏一种有针对性的产品,在日常的口腔护理上给与预防和控制。
蛀牙疼痛、出血因为在头部,会引发牙神经疼痛波及面部神经,因而发作时痛苦异常。俗语云:牙疼不是病,疼起来要命!有时疼痛引起炎症,还会出现肿胀,牵扯面部肌肉,波及吞咽及形象。
另外一种常见口腔疾病是:口腔溃疡。在口腔黏膜疾病中发病率非常高,它的特点是多因素引起,反复发作,感冒、精神紧张、抑郁等情况都能引起该病的发生,一般在1—2周左右能自愈。由于过程较长且疼痛,常给患者带来不便和痛苦。口腔溃疡常见于唇、颊、舌缘等,在黏膜的任何部位均能出现。
传统中医药所用原料大多为植物或矿物成分。其中,植物一般为根、茎、叶等提取物,经过几千年的筛选与实践。目前,列入《中国药典》的中草药已有近3800种,独特的药用价值及安全性,得到不断的证实,疗效明显,可谓中华民族的瑰宝。随着科技水平的不断提高,原料可用分析方法明确其活性成分,同时进行定性或定量的检测。
中草药成分在口腔用品中的应用有着悠久历史。如用于治疗口腔溃疡的蒲公英,《医林纂要》中记载“蒲公英能化热毒,解食毒,消肿核,疗疔毒乳痈,皆泻火安上之功。通乳汁,以形用也。固齿牙,去阳阴热也。人言一茎两花,高尺许,根下大如拳,旁有人形拱抱,捣汁酒和,治噎隔神效。吾所见皆一茎一花,亦鲜高及尺者,然以治噎膈。”又如三七,《本草纲目》记载“止血散血定痛,金刃箭伤、跌扑杖疮、血出不止者,嚼烂涂,或为末掺之,其血即止。亦主吐血衄血,下血血痢,崩中经水不止,产后恶血不下,血运血痛,赤目痈肿,虎咬蛇伤诸病。”自古有用三七捣烂敷患处用于止血的功效。
目前临床用于治疗口腔炎症、口腔溃疡的药物,大多采用一些成分较为单一的西药或中药,存在药效慢、有一定的毒副作用,会对胃肠等其他器官造成一定程度的伤害,易产生耐药性、且容易复发等问题。
因此开发出一款绿色安全、高效消炎镇痛止血的复方中药势在必行。
发明内容
为了克服上述现有技术存在的缺陷,本发明的目的在于提供一种治疗蛀牙疼痛、出血、口腔溃疡、止血镇痛消炎的中药组合物及护理产品。
本发明是通过以下技术方案来实现:
一种治疗蛀牙疼痛、出血,口腔溃疡,止血镇痛消炎的中药组合物,以质量份数计,包括100-150白芍药、70-120份蒲公英、50-120份海螵蛸、50-200份海盐、70-150份三七、40-90份生石膏、50-100份藿香、80-140份骨碎补、30-80份薄荷、50-100份黄芩、50-100份花椒。
优选的:一种治疗蛀牙疼痛、出血,口腔溃疡,止血镇痛消炎的中药组合物,以质量份数计,100-120份白芍药、70-100份蒲公英、50-100份海螵蛸、50-150份海盐、70-120份三七、40-70份生石膏、50-90份藿香、80-120份骨碎补、30-70份薄荷、50-90份黄芩、50-80份花椒。
更优选的:一种治疗蛀牙疼痛、出血,口腔溃疡,止血镇痛消炎的中药组合物,以质量份数计,100份白芍药、70份蒲公英、50份海螵蛸、50份海盐、70份三七、40份生石膏、50份藿香、80份骨碎补、30份薄荷、50份黄芩、50份花椒。
组合物中以白芍药为君药,蒲公英、三七、骨碎补为臣药,其余为佐使。
白芍药:性苦;酸;微寒,归肝、脾经。平肝止痛,养血调经,敛阴止汗的功效。本方中以白芍为君药,有蛀牙问题的情况下,可以通过预防肝火胃火上升导致的疼痛出血,先从基本上去解决底层问题。
蒲公英:味苦;甘;性寒,归肝、胃经。有清热解毒;消痈散结作用。蒲公英是一种天然的消炎药,有良好的抗菌作用,对于因为食物残渣产生的细菌侵蚀引发的疼痛,压迫牙神经导致的出血,有良好的抑制作用。天然的抗菌作用还不产生耐药性和依赖性,可以放心长期使用。
三七:味甘;微苦;性温,归肝、胃经。有止血;散瘀止血,消肿定痛。三七是一种天然的消肿止痛药,当蛀牙疼痛,出血症状出现时,用户的第一诉求就是解决这个燃眉之急的痛楚,三七可以及时的解决这个问题。
骨碎补:味苦;性温,归肾、肝经。有治肾虚久泻及腰痛,风湿痹痛,治肾虚牙痛、齿龈出血(牙周病等)作用。中医讲究从根本上去看问题,从整体上去解决问题,注重事物的内在联系。从祖国医学角度出发,齿为骨之末,当牙齿出现问题,从根源上是肾气不足,劳损,导致牙齿容易受到外界侵蚀。那么就从根源上去解决这个方面的不足,亡羊补牢,让牙齿,牙龈受到良好的保护,建立良好的屏障,免受不良外因的侵害和困扰。
广藿香含挥发油约1.5%,油中主成分为广藿香醇,约占52~57%;其他成分有苯甲醛、丁香油酚等,具有快气,和中,辟秽,祛湿之功效。同时具治感冒暑湿,寒热,头痛,胸脘痞闷,呕吐泄泻,疟疾,痢疾,口臭等作用。本配方中添加藿香,是为与蒲公英共同形成强大的抗菌作用,同时藿香的快气和祛湿作用,可以去除口中的黏腻,让口腔保持舒爽,有效促进修复作用。藿香的另外一个作用是清新口气,避免蛀牙出血形成的口臭。同时不会像牙膏一样,使用后有很浓的牙膏味,而是香气清新自然。
再加上其他中草药的共同作用,具有良好的消炎镇痛,促进溃疡面愈合,止血,抑菌等方面的作用,对于改善蛀牙疼痛、出血,牙周炎、牙龈出血、口腔溃疡等口腔问题具有积极的促进作用,同时因其不含西药止血成分,不含西药抗生素,不含化工物质,因而无毒副作用,从根源上解决问题且无副作用。
本配方采用多种中草药植物共同组方搭配,经过研磨成粉剂,提取成液体,可以刷牙、含漱。相对于市面上其他口腔产品利用化工原料进行口腔清洁和杀菌,本产品主要在于通过草本植物的抗菌、止痛、消炎的作用,有效预防上述症状的发生,同时经常形成良好的口腔保护作用。纯本草制作,绿色安全有效。
具体实施方式
下面结合实施例对本发明作进一步详细说明,但并不用于限定本发明。
实施例:
实施例1:一种中药组合物,以质量份数计,100份白芍药、70份蒲公英、50份海螵蛸、50份海盐、70份三七、40份生石膏、50份藿香、80份骨碎补、30份薄荷、50份黄芩、50份花椒。
实施例2:110份白芍药、80份蒲公英、100份海螵蛸、80份海盐、90份三七、50份生石膏、70份藿香、100份骨碎补、50份薄荷、70份黄芩、70份花椒。
对比例1:一种中药组合物,以质量份数计,70份蒲公英、50份海螵蛸、50份海盐、70份三七、40份生石膏、50份藿香、80份骨碎补、30份薄荷、50份黄芩、50份花椒。
对比例2:一种中药组合物,以质量份数计,100份白芍药、70份蒲公英、50份海螵蛸、50份海盐、40份生石膏、50份藿香、80份骨碎补、30份薄荷、50份黄芩、50份花椒。
对比例3:一种中药组合物,以质量份数计,100份白芍药、50份海螵蛸、50份海盐、70份三七、40份生石膏、50份藿香、80份骨碎补、30份薄荷、50份黄芩、50份花椒。
实验1
中药组合物在治疗蛀牙疼痛、出血,口腔溃疡方面的临床效果观察
实验方法:使用实施例1-2,对比例1-2的组合物(其中口腔溃疡和牙龈肿痛出血各4组)进行试验,每组选20人进行试验,。年龄从14岁到72岁不等,男女比例接近1:1;由医生指导病人使用上述组合物0.8g敷于口腔患处(口腔溃疡处或牙龈肿痛出血处),要求病人每天使用2次,每次3分钟以上,敷药期间采用仅有清洁功能的牙膏。病人分别使用实施例和对照例中的组合物后,第2天,第7天和第2周复诊检查并记录。第一次就诊及随后每一次复查记录内容包括口腔溃疡数目、大小、疼痛程度及每次口腔溃疡发作的病程等。统计第7天患者的口腔溃疡情况和地14天的牙龈肿痛情况,结果如表1所示:
有效率=有效人数/每组总调查人数×100%
表1
处理 | 口腔溃疡有效率 | 牙龈肿痛出血有效率 |
实施例1 | 100% | 100% |
实施例2 | 95% | 100% |
对比例1 | 75% | 70% |
对比例2 | 55% | 65% |
对比例3 | 55% | 55% |
实验2,将实施例1加入常规助剂制成牙膏,用于有蛀牙疼痛、出血,口腔溃疡的病人,
7天后观察效果如表2:
通过表1数据可知,若去掉白芍药、三七或蒲公英,组合物对蛀牙疼痛、出血,口腔溃疡的有效率都有相当的折扣。
如果去掉白芍药,同样是有消肿止痛的效果,抗菌消炎的作用,但是没有从根本去引导症状的走向,没有从根本上着手,就容易反弹,好了之后容易出现反复的疼痛及出血。就好比构建一座大厦,地基是基础,把地基打牢,这座大厦能承受更多的力,才够持久。
同时,三七与蒲公英具有协同作用,两者缺一不可。
通过表2实验数据可知,用实施例1组合物的配方制成的牙膏具有预防出血、消炎镇痛、清热解毒、固齿健龈、消毒抑菌和清洁作用,比市面上一般的牙膏和牙粉效果好很多,同时,因其没有化工和西药成分,它没有相应的毒副效果,更具保健效果。
综上所述,本申请的方案用于蛀牙疼痛、出血,口腔溃疡均具有优异的治疗效果,将其制成牙膏或敷料使用。
制成牙膏加入成分:矿物质水/等离子水,透明啫喱(黄原胶、角叉菜胶),甘油,月桂醇硫酸酯钠等。
Claims (5)
1.一种治疗蛀牙疼痛、出血,口腔溃疡,止血镇痛消炎的中药组合物,其特征在于,以质量份数计,包括100-150白芍药、70-120份蒲公英、50-120份海螵蛸、50-200份海盐、70-150份三七、40-90份生石膏、50-100份藿香、80-140份骨碎补、30-80份薄荷、50-100份黄芩、50-100份花椒。
2.根据权利要求1所述的中药组合物,其特征在于,以质量份数计,100-120份白芍药、70-100份蒲公英、50-100份海螵蛸、50-150份海盐、70-120份三七、40-70份生石膏、50-90份藿香、80-120份骨碎补、30-70份薄荷、50-90份黄芩、50-80份花椒。
3.根据权利要求1所述的中药组合物,其特征在于,以质量份数计,包括100份白芍药、70份蒲公英、50份海螵蛸、50份海盐、70份三七、40份生石膏、50份藿香、80份骨碎补、30份薄荷、50份黄芩、50份花椒。
4.根据权利要求1-3所述任一项中药组合物在制备治疗蛀牙疼痛、出血,口腔溃疡,止血镇痛消炎制剂的用途。
5.一种根据权利要求1-3所述任一项中药组合物制备的牙膏,其特征在于,还含有:水,黄原胶、角叉菜胶,甘油,月桂醇硫酸酯钠。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210801006.3A CN115068533A (zh) | 2022-07-08 | 2022-07-08 | 一种防治口腔疾病的中药组合物及护理产品 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210801006.3A CN115068533A (zh) | 2022-07-08 | 2022-07-08 | 一种防治口腔疾病的中药组合物及护理产品 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN115068533A true CN115068533A (zh) | 2022-09-20 |
Family
ID=83258435
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210801006.3A Pending CN115068533A (zh) | 2022-07-08 | 2022-07-08 | 一种防治口腔疾病的中药组合物及护理产品 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN115068533A (zh) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102145077A (zh) * | 2011-03-18 | 2011-08-10 | 王磊 | 一种治疗急性牙周炎的口腔中药制剂 |
CN104161714A (zh) * | 2014-08-29 | 2014-11-26 | 南京科技广场科技发展有限公司 | 中药保健牙膏 |
CN105616270A (zh) * | 2015-06-30 | 2016-06-01 | 贾简华 | 一种中草药牙膏及其制备方法 |
-
2022
- 2022-07-08 CN CN202210801006.3A patent/CN115068533A/zh active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102145077A (zh) * | 2011-03-18 | 2011-08-10 | 王磊 | 一种治疗急性牙周炎的口腔中药制剂 |
CN104161714A (zh) * | 2014-08-29 | 2014-11-26 | 南京科技广场科技发展有限公司 | 中药保健牙膏 |
CN105616270A (zh) * | 2015-06-30 | 2016-06-01 | 贾简华 | 一种中草药牙膏及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Suhag et al. | Role of curcumin as a subgingival irrigant: a pilot study. | |
CN108464963B (zh) | 一种用于口腔的组合物及其应用和制备方法 | |
US11806376B2 (en) | Pharmaceutical composition for treating oral ulcer and preparation method and application thereof | |
CN106511185A (zh) | 一种防治牙龈出血的牙膏及其制备方法 | |
CN101085100A (zh) | 一种内服治疗牙痛的中药组合物 | |
CN104983752B (zh) | 一种治疗口腔疾病的中药组合物、口腔用品及制备方法 | |
CN108420768A (zh) | 一种消炎止血的护龈牙膏及其制备方法 | |
WO2021225918A1 (en) | Semi-solid chewable compositions and methods of making and using thereof | |
CN101007088A (zh) | 一种治疗牙周疾病的中药组合物及其制备方法 | |
Prakash et al. | Effect of punica granatum extract gel on gingival crevicular fluid levels of interleukin-1β, interleukin-8 and CCL28 levels: randomised controlled clinical trial | |
US20090232749A1 (en) | Compositions for the acute and/or long term treatment of periodontal diseases | |
CN115068533A (zh) | 一种防治口腔疾病的中药组合物及护理产品 | |
CN112076221B (zh) | 一种脱敏糊剂及其制备方法和用途 | |
CN111743838A (zh) | 一种中药漱口水及其制备方法 | |
CN112137928A (zh) | 一种多重功效牙膏及其制备方法 | |
CN111329903B (zh) | 一种中药组合物及其应用 | |
CN103933274A (zh) | 一种治疗牙周炎的中药制剂 | |
CN114404522B (zh) | 中草药组合物、漱口剂及制备方法 | |
CN105535246B (zh) | 一种用于治疗牙周炎的现代中药制剂及其制备方法 | |
CN112933122B (zh) | 一种治疗复发性口腔溃疡的中药外用药物 | |
CN109646591B (zh) | 一种用于口腔的组合物及其应用 | |
CN111388553B (zh) | 一种能够预防和治疗牙周病的蒙药制剂 | |
CN107744549A (zh) | 一种治疗牙痛的药物及其制备方法 | |
CN114146125B (zh) | 一种抑制口腔感染幽门螺杆菌的中药组合物 | |
CN107412524A (zh) | 治疗蛀牙的药物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20220920 |
|
RJ01 | Rejection of invention patent application after publication |